I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
The purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors. This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when given …
follicular thyroid cancer
pet/ct scan
anticoagulation therapy
copanlisib
braf v600 mutation
- 0 views
- 19 Feb, 2024